{"@context":{"@vocab":"https://schema.org/","dcterms":"http://purl.org/dc/terms/","prov":"http://www.w3.org/ns/prov#"},"@type":"ItemList","@id":"https://api.morvs.ai/api/v1/entity/PLRZ/timeline","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://api.morvs.ai/license","usage_info":"https://api.morvs.ai/license","rights":"Source-specific terms apply; free or keyless access does not alter them.","generated_at":"2026-10-17T01:27:20.964Z","methodology_url":"https://api.morvs.ai/datasets/","primary_sources":{"sec.*":"https://www.sec.gov/edgar","fda.*":"https://api.fda.gov/","contracts":"https://api.usaspending.gov/","clinical.trials":"https://clinicaltrials.gov/","lobbying.filings":"https://lda.senate.gov/","epa.facilities":"https://echo.epa.gov/","court.dockets":"https://www.courtlistener.com/","cfpb.complaints":"https://www.consumerfinance.gov/data-research/consumer-complaints/","nih.grants":"https://api.reporter.nih.gov/","fed.enforcement":"https://www.federalreserve.gov/supervisionreg/enforcementactions.htm","nhtsa.recalls":"https://api.nhtsa.gov/recalls/"}},"entity":{"entity_id":7301,"canonical_name":"Polyrizon Ltd.","cik":"0001893645","uei":null,"lei":null,"duns":null,"ticker":"PLRZ"},"window_days":180,"min_importance":0,"sources_queried":["sec.filings","sec.insider","sec.form144","sec.13dg","fda.recalls","fda.labels","contracts","clinical.trials","lobbying.filings","epa.facilities","uspto.patents","court.dockets","cfpb.complaints","nih.grants","fed.enforcement","nhtsa.recalls","doj.press","dol.form5500"],"importance_reference":{"fda.recall Class I":100,"clinical trial terminated":80,"securities class action":80,"antitrust suit":75,"schedule 13D":75,"patent litigation":70,"form144 large ($50M+)":75,"10-K restatement":75,"phase3 trial completed":70,"EPA significant violator":70,"phase3 trial in progress":60,"insider purchase":50,"phase2 trial":45,"8-K":35,"lobbying filing":30,"fda.label":30,"phase1 trial":30,"fda.recall Class III":25},"vertical_counts":{"sec":24,"clinical":1},"count":25,"timeline":[{"ts":"2026-10-07","kind":"sec.filing","form_type":"S-8","title":"S-8 — Polyrizon Ltd. — 2026-10-07","url_slug":"/sec/cik-0001893645/s-8/0001213900-26-107582","accession_number":"0001213900-26-107582","importance":30},{"ts":"2026-10-05","kind":"sec.filing","form_type":"6-K","title":"6-K — Polyrizon Ltd. — 2026-10-05","url_slug":"/sec/cik-0001893645/6-k/0001213900-26-106814","accession_number":"0001213900-26-106814","importance":30},{"ts":"2026-10-01","kind":"sec.filing","form_type":"EFFECT","title":"EFFECT — Polyrizon Ltd. — 2026-10-01","url_slug":"/sec/cik-0001893645/effect/9999999995-26-003133","accession_number":"9999999995-26-003133","importance":30},{"ts":"2026-09-28","kind":"sec.filing","form_type":"6-K","title":"6-K — Polyrizon Ltd. — 2026-09-28","url_slug":"/sec/cik-0001893645/6-k/0001213900-26-104045","accession_number":"0001213900-26-104045","importance":30},{"ts":"2026-09-28","kind":"sec.filing","form_type":"F-1/A","title":"F-1/A — Polyrizon Ltd. — 2026-09-28","url_slug":"/sec/cik-0001893645/f-1-a/0001213900-26-104062","accession_number":"0001213900-26-104062","importance":30},{"ts":"2026-09-18","kind":"sec.filing","form_type":"F-1","title":"F-1 — Polyrizon Ltd. — 2026-09-18","url_slug":"/sec/cik-0001893645/f-1/0001213900-26-101441","accession_number":"0001213900-26-101441","importance":30},{"ts":"2026-09-10","kind":"sec.filing","form_type":"D","title":"D — Polyrizon Ltd. — 2026-09-10","url_slug":"/sec/cik-0001893645/d/0001213900-26-098803","accession_number":"0001213900-26-098803","importance":30},{"ts":"2026-09-04","kind":"sec.filing","form_type":"424B5","title":"424B5 — Polyrizon Ltd. — 2026-09-04","url_slug":"/sec/cik-0001893645/424b5/0001213900-26-097441","accession_number":"0001213900-26-097441","importance":30},{"ts":"2026-09-04","kind":"sec.filing","form_type":"6-K","title":"6-K — Polyrizon Ltd. — 2026-09-04","url_slug":"/sec/cik-0001893645/6-k/0001213900-26-097444","accession_number":"0001213900-26-097444","importance":30},{"ts":"2026-09-04","kind":"sec.filing","form_type":"6-K","title":"6-K — Polyrizon Ltd. — 2026-09-04","url_slug":"/sec/cik-0001893645/6-k/0001213900-26-097696","accession_number":"0001213900-26-097696","importance":30},{"ts":"2026-08-20","kind":"sec.filing","form_type":"6-K","title":"6-K — Polyrizon Ltd. — 2026-08-20","url_slug":"/sec/cik-0001893645/6-k/0001213900-26-092083","accession_number":"0001213900-26-092083","importance":30},{"ts":"2026-07-13","kind":"sec.filing","form_type":"6-K","title":"6-K — Polyrizon Ltd. — 2026-07-13","url_slug":"/sec/cik-0001893645/6-k/0001213900-26-077540","accession_number":"0001213900-26-077540","importance":30},{"ts":"2026-07-02","kind":"sec.filing","form_type":"6-K","title":"6-K — Polyrizon Ltd. — 2026-07-02","url_slug":"/sec/cik-0001893645/6-k/0001213900-26-074946","accession_number":"0001213900-26-074946","importance":30},{"ts":"2026-06-29","kind":"sec.filing","form_type":"6-K","title":"6-K — Polyrizon Ltd. — 2026-06-29","url_slug":"/sec/cik-0001893645/6-k/0001213900-26-073097","accession_number":"0001213900-26-073097","importance":30},{"ts":"2026-06-17","kind":"sec.filing","form_type":"6-K","title":"6-K — Polyrizon Ltd. — 2026-06-17","url_slug":"/sec/cik-0001893645/6-k/0001213900-26-069614","accession_number":"0001213900-26-069614","importance":30},{"ts":"2026-06-15","kind":"sec.filing","form_type":"6-K","title":"6-K — Polyrizon Ltd. — 2026-06-15","url_slug":"/sec/cik-0001893645/6-k/0001213900-26-068760","accession_number":"0001213900-26-068760","importance":30},{"ts":"2026-06-10","kind":"sec.filing","form_type":"6-K","title":"6-K — Polyrizon Ltd. — 2026-06-10","url_slug":"/sec/cik-0001893645/6-k/0001213900-26-067307","accession_number":"0001213900-26-067307","importance":30},{"ts":"2026-06-08","kind":"sec.filing","form_type":"6-K","title":"6-K — Polyrizon Ltd. — 2026-06-08","url_slug":"/sec/cik-0001893645/6-k/0001213900-26-066266","accession_number":"0001213900-26-066266","importance":30},{"ts":"2026-06-08","kind":"sec.filing","form_type":"6-K","title":"6-K — Polyrizon Ltd. — 2026-06-08","url_slug":"/sec/cik-0001893645/6-k/0001213900-26-066267","accession_number":"0001213900-26-066267","importance":30},{"ts":"2026-06-05","kind":"sec.filing","form_type":"6-K","title":"6-K — Polyrizon Ltd. — 2026-06-05","url_slug":"/sec/cik-0001893645/6-k/0001213900-26-065790","accession_number":"0001213900-26-065790","importance":30},{"ts":"2026-05-15","kind":"clinical.trial","reporter":"Polyrizon Ltd.","title":"Evaluation of the Efficacy, Safety, and Tolerability of PL-14 Allergy Blocker Compared to Saline Spray in Patients With Seasonal Allergic Rhinitis","security_title":"NA","status":"NOT_YET_RECRUITING","accession_number":"NCT07588672","excerpt":"[\"Seasonal Allergic Rhinitis (SAR)\",\"Allergic Rhinitis\"]","importance":25},{"ts":"2026-05-13","kind":"sec.filing","form_type":"6-K","title":"6-K — Polyrizon Ltd. — 2026-05-13","url_slug":"/sec/cik-0001893645/6-k/0001213900-26-055510","accession_number":"0001213900-26-055510","importance":30},{"ts":"2026-04-30","kind":"sec.filing","form_type":"CORRESP","title":"CORRESP — Polyrizon Ltd. — 2026-04-30","url_slug":"/sec/cik-0001893645/corresp/0001213900-26-050349","accession_number":"0001213900-26-050349","importance":30},{"ts":"2026-04-28","kind":"sec.filing","form_type":"UPLOAD","title":"UPLOAD — Polyrizon Ltd. — 2026-04-28","url_slug":"/sec/cik-0001893645/upload/0000000000-26-004342","accession_number":"0000000000-26-004342","importance":30},{"ts":"2026-04-27","kind":"sec.filing","form_type":"6-K","title":"6-K — Polyrizon Ltd. — 2026-04-27","url_slug":"/sec/cik-0001893645/6-k/0001213900-26-047794","accession_number":"0001213900-26-047794","importance":30}]}